TETERBORO, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Executive Officer, is scheduled to speak at the Banc of America
Securities 34th Annual Investment Conference on Monday, September 20, 2004, at
The Ritz-Carlton Hotel in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 11:00 a.m. Eastern Time, followed by a
breakout session at 11:30 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://www.veracast.com/webcasts/bas/34th-annual-2004/id01102515.cfm and to
the public on http://www.questdiagnostics.com. The link for the breakout
session is:
http://www.veracast.com/webcasts/bas/34th-annual-2004/id72104081.cfm
In addition, the archived webcast will be available starting two hours after
the presentation.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
healthcare professionals to make decisions that improve health. The company
offers the broadest access to diagnostic testing services through its national
network of laboratories and patient service centers, and provides interpretive
consultation through its extensive medical and scientific staff. Quest
Diagnostics is the leading provider of esoteric testing, including gene-based
medical testing, and provides advanced information technology solutions to
improve patient care. Additional company information is available at:
http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2003 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics
-0- 09/17/2004
/CONTACT: Investors: Laure Park, +1-201-393-5030, Media: Gary Samuels,
+1-201-393-5700, both for Quest Diagnostics /
/Web site: http://www.questdiagnostics.com /
(DGX)